Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK1 | P49759 | 4/20 | 0.76 |
| ▸ | CNR1 | P21554 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 5/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | ACP1 | P24666 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13778842 | 0.83 | CNR1 (0.72) | CLK1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL28529053 | 0.82 | CNR1 (0.70) | CLK1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL30944353 | 0.82 | CNR1 (0.70) | CLK1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL4920969 | 0.81 | NPC1 (0.75) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4252873 | 0.79 | CNR1 (0.63) | CLK1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL4918014 | 0.79 | CNR1 (1.00) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15376878 | 0.79 | ALDH1A1 (0.74) | CLK1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL31744843 | 0.78 | ALDH1A1 (0.58) | CLK1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30944323 | 0.77 | CNR1 (0.64) | CLK1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL28527319 | 0.77 | CNR1 (0.64) | CLK1CNR1ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086855-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2011-04-14 | — | — | US | disclosed |
| US-7875639-B2 | Compounds as cannabinoid receptor ligands and uses thereof | ABBOTT LABORATORIES (US) | 2011-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086855-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | CNR1, CNR2, OPRL1 | CLK1 2342/4885CNR1 1/4885ALDH1A1 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.